This is a Validated Antibody Database (VAD) review about human CD52, based on 9 published articles (read how Labome selects the articles), using CD52 antibody in all methods. It is aimed to help Labome visitors find the most suited CD52 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD52 synonym: CDW52; EDDM5; CAMPATH-1 antigen; CD52 antigen (CAMPATH-1 antigen); CDW52 antigen (CAMPATH-1 antigen); HEL-S-171mP; cambridge pathology 1 antigen; epididymal secretory protein E5; epididymis secretory sperm binding protein Li 171mP; he5; human epididymis-specific protein 5

Bio-Rad
rat monoclonal (YTH66.9HL)
  • other; human; 200 ug/ml; fig 3
Bio-Rad CD52 antibody (AbDSerotec, MCA349) was used in other on human samples at 200 ug/ml (fig 3). J Extracell Vesicles (2016) ncbi
rat monoclonal (YTH34.5)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Bio-Rad CD52 antibody (Serotech, YTH34.5) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
rat monoclonal (YTH34.5)
  • immunocytochemistry; human
Bio-Rad CD52 antibody (AbD Serotec, YTH34.5) was used in immunocytochemistry on human samples . FASEB J (2014) ncbi
mouse monoclonal (HI186)
  • flow cytometry; human
Bio-Rad CD52 antibody (AbD Serotec, clone HI186) was used in flow cytometry on human samples . Leuk Lymphoma (2012) ncbi
BioLegend
mouse monoclonal (HI186)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD52 antibody (BioLegend, HI186) was used in flow cytometry on human samples (fig s1b). Genome Biol (2017) ncbi
mouse monoclonal (HI186)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend CD52 antibody (BioLegen d, 316006) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Invitrogen
mouse monoclonal (CF1D12)
  • flow cytometry; human; fig 1g
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, Invitrogen CD52 antibody (Life Technologies, CF1D12) was used in flow cytometry on human samples (fig 1g). Cytometry B Clin Cytom (2017) ncbi
rat monoclonal (YTH34.5)
  • flow cytometry; human; fig 3
In order to determine the immunophenotypic profile of B-CLL subsets with different prognoses, Invitrogen CD52 antibody (Biosource, YTH34.5) was used in flow cytometry on human samples (fig 3). J Immunol Methods (2005) ncbi
rat monoclonal (YTH34.5)
  • flow cytometry; human
In order to use flow cytometry to characterize 123 cases of B-cell chronic lymphocytic leukemia, Invitrogen CD52 antibody (Biosource, YTH34.5) was used in flow cytometry on human samples . J Cell Physiol (2005) ncbi
Articles Reviewed
  1. Litzenburger U, Buenrostro J, Wu B, Shen Y, Sheffield N, Kathiria A, et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol. 2017;18:15 pubmed publisher
  2. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  3. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  4. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  5. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  6. Hoermann G, Blatt K, Greiner G, Putz E, Berger A, Herrmann H, et al. CD52 is a molecular target in advanced systemic mastocytosis. FASEB J. 2014;28:3540-51 pubmed publisher
  7. Nguyen T, Havari E, McLaren R, Zhang M, Jiang Y, Madden S, et al. Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes. Leuk Lymphoma. 2012;53:699-709 pubmed publisher
  8. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, et al. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. J Immunol Methods. 2005;305:20-32 pubmed
  9. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, et al. Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol. 2005;204:113-23 pubmed